Cancer

Understanding Clinical Trials and What They Mean for Cancer Patients, Medicine

For many people, the concept of participating in a clinical trial is intimidating, frightening and unappealing.

But local physician-scientists will remind naysayers that anyone who takes a medication or has a medical treatment is able to do so because of clinical research. And that research was made possible because average people volunteered to participate in it.

Misconceptions about Clinical Trials

There are three common public misperceptions about clinical trials that cause people to shy away:

Research trials are only for people have no other options

Patients are randomly experimented on “like guinea pigs”

Some patients are denied treatment entirely

One of the biggest myths out there is that clinical trials are only for people with no other choices. There are clinical trials for every stage of disease as well as prevention and early detection, and they all have value.

Clinical trials are the last step in a carefully regulated, detailed scientific process that starts in a laboratory in cells or tissue and is then tested in humans—oftentimes years later and always after strenuous review.

Medical studies are supervised by a local physician and look at every stage of disease, from first diagnosis to advanced disease. All are designed to find, diagnose, treat or prevent cancer.

Clinical trials exist to answer questions and allow us to learn better ways to treat specific diseases. It is the only way medicine can move forward. Every new drug must be studied to avoid unforeseen negative outcomes and avoid treatments that aren’t beneficial. Even though not everyone who participates in a clinical trial will receive the investigational therapy, everyone does get the same standard of care they would if they didn’t participate.

Types of Clinical Trials

There are four basic types of clinical trials:

TREATMENT trials test a new approach to medical treatments such as surgery, radiation therapy and new medications as well as different combinations of existing treatment or new methods, such as gene therapy.

PREVENTION trials seek to stop cancer from ever developing through the use of preventative vitamins, minerals or medications.

SCREENING trials are aimed at finding cancer earlier through imaging or blood tests. The goal is to detect cancers in early stage development when they are typically more treatable.

QUALITY OF LIFE/SUPPORTIVE CARE TRIALS focus on ways of helping people with cancer deal with the complications of treatment—both mental and physical. These may include things like sexual desire or fatigue.

Before a patient is enrolled in a clinical trial, the individual is carefully screened against a set of criteria designed to create a group of people that are as similar as possible.

Qualification depends on a variety of factors including stage of disease, existing health conditions and other factors. The criteria for each trial are very specific to avoid including anyone in a trial that doesn’t fit.

The patient then goes through what is known as “informed consent” where the goals of the trial, why it is needed and how it will work are explained in easily understandable terms.

Patients should take the time to discuss all the details of a clinical trial with their doctor and family before agreeing to participate. It is important to keep asking questions until the patient is 100 percent comfortable with their decision to participate.

Those questions might include information about costs, time commitments, potential benefits as well as side effects. This may vary, based on where the new therapy or tool is in development and testing process (phases).

Phase I and phase II trials focus primarily on safety of the new treatment. Phase I trials are investigational and therefore include a very small number of people—about 15 to 30 people. The goal is to determine safe medical dosage, the best method of delivery (for example, a pill or fluids) and potential side effects. Phase II trials seek to determine if a new therapy has a specific effect on a certain type of cancer in a slightly larger population group of less than 100 people.

Phase III, IV and V trials focus on larger-scale testing to compare the investigational medical treatment to the standard of care and further assess its long-term safety and effectiveness. These trials may require a longer time commitment and more paper surveys.

Stringent patient protections implemented to ensure safety and ethical conduct are monitored by an Institutional Review Board (IRB), a governing committee made up of physicians, scientists and members of the community responsible for scientific review and approval of all clinical research studies. Other medical monitoring groups are in place to ensure medical oversight and ethical conduct throughout the clinical research process.

It is important to note that if a new drug or therapy doesn’t show enough benefit to the target population in the early stages of human testing, it does not move forward.

The IRB is essentially a medical watchdog put in place to protect patients. They ensure that the medical risks are reasonable compared to the possible benefits of a clinical study.

Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More)